| |
|
|
Drug name
|
Condition |
Division |
| Naglazyme® (galsulfase) |
MPS VI |
Accredo Therapeutics |
| Neulasta® (pegfilgrastim) |
Anemia/Neutropenia |
Accredo Nova Factor |
| Neumega® (oprelvekin) |
Thrombocytopenia |
Accredo Nova Factor |
| Neupogen® (filgrastim) |
Anemia/Neutropenia |
Accredo Nova Factor |
| Nexavar® (sorafenib) |
Oncology |
Accredo Nova Factor |
| Norditropin Nordiflex® (somatropin [rDNA origin]) |
Growth Disorders |
Accredo Nova Factor |
| Novantrone® (mitoxantrone) |
Multiple Sclerosis |
Accredo Nova Factor |
| Novarel® (chorionic gonadotropin) |
Infertility |
Accredo Nova Factor |
| NovoSeven® RT (coagulation factor VIIa [recombinant]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| Nplate™ (romiplostim) |
Thrombocytopenia |
Accredo Nova Factor |
| Nutropin® (somatropin [rDNA origin]) |
Growth Disorders |
Accredo Nova Factor |
| Nutropin AQ® (somatropin [rDNA origin]) |
Growth Disorders |
Accredo Nova Factor |